For years, the antipsychotic drug Risperdal (risperidone) was widely prescribed to treat conditions like schizophrenia, bipolar disorder, and irritability in individuals with autism. But behind the promises of symptom relief lies a disturbing reality: Risperdal has been linked to severe health complications, and now, thousands of patients and families are taking legal action.
Manufactured by Johnson & Johnson, Risperdal has come under intense scrutiny for its dangerous side effects and alleged failure to properly warn patients and doctors. Among the most alarming risks: an increased likelihood of developing breast growth in males (gynecomastia) and serious hormonal imbalances, and now, emerging legal claims link Risperdal to certain types of cancer.
Common Uses for Risperdal
Risperdal was approved by the FDA for several conditions, including:
- Schizophrenia in adults and adolescents
- Bipolar disorder (as a mood stabilizer)
- Autism-related irritability in children
Despite these approvals, the drug was aggressively promoted for off-label uses, including for elderly patients with dementia, a population especially vulnerable to side effects.
What Makes Risperdal So Dangerous?
Risperdal works by affecting brain chemicals, such as dopamine and serotonin. However, this disruption can lead to increased levels of prolactin, a hormone that can trigger abnormal tissue growth, particularly in males.
Lawsuits allege that Johnson & Johnson was aware of these risks but failed to warn doctors and patients, thereby putting lives at risk for the sake of profit.
Health Risks Associated with Risperdal
Studies and legal findings have connected Risperdal use to a range of serious health issues, especially when used long-term or during adolescence:
- Gynecomastia (male breast growth)
- Pituitary gland tumors
- Hormone-driven cancers (including breast and pituitary tumors)
- Emotional trauma and social consequences in adolescent boys
- Elevated prolactin levels that may lead to tumor development
- Stroke and death in elderly dementia patients
Thousands of Lawsuits and Major Settlements
Johnson & Johnson has already paid billions in Risperdal-related settlements. In 2019, a jury awarded $8 billion in damages in a high-profile case involving male breast growth. Thousands more cases have been filed by individuals who claim Risperdal caused irreversible physical and emotional harm.
As of 2024, Risperdal litigation is expanding to include claims related to hormone-related cancers. Attorneys are actively reviewing cases where patients developed pituitary tumors, breast cancer, or other endocrine-related malignancies after Risperdal use.
Who May Be Eligible for Compensation?
You or a loved one may qualify for a Risperdal lawsuit if you:
- Were prescribed Risperdal as a child, teen, or adult
- Developed gynecomastia or had to undergo breast reduction surgery
- Were diagnosed with a hormone-related tumor or cancer
- Experienced emotional distress or social withdrawal due to side effects
How to Take Action
Victims are stepping forward to hold Johnson & Johnson accountable for the harm caused by Risperdal. If you or someone you love suffered serious health effects after taking this drug, you may be entitled to financial compensation for medical bills, emotional suffering, and long-term care.
Click the button below to see if you qualify:
- Complete a brief 30-second form
- No fees unless you win
- Confidential case review
Don’t Wait – Time to File May Be Limited
Thousands have already filed, and more cases are expected. Get the justice you deserve and help protect others from this dangerous drug.
Take the first step today.




